My view is AFMD is more of a data before belief stock or 'show -me'
It's cheap and exciting science, but not sure when it will get momentum. The real binary event will be AFMD13 data in 2016.
I don't expect the data coming up here in early November to move the stock much. EGFRvIII is the same target as Celdex's Rindopepimut. Not the same MOA.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.